Key Trends Reshaping the Veterinary CRO And CDMO Market: Product Innovations In Veterinary Soft Chew Technology Industry Transformation

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Veterinary CRO And CDMO Market Size Growth Forecast: What to Expect by 2025?
In recent times, the size of the veterinary CRO and CDMO market has seen robust growth. The growth is projected to increase from $6.97 billion in 2024 to $7.53 billion in 2025, recording an annual compound growth rate (CAGR) of 8.0%. The growth during the historic period is a result of various factors such as the need for regulatory adherence, the global expansion of the animal health market, increased development of drugs for livestock, and increased outsourcing by pharmaceutical companies.

How Will the Veterinary CRO And CDMO Market Size Evolve and Grow by 2029?
In the coming years, the veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is anticipated to experience robust growth. The market's projected value is $10.71 billion in 2029 and represents a 9.2% compound annual growth rate (CAGR). This growth during the period could be due to the prevalence of precision medicine, an emphasis on preventative healthcare, epidemiological monitoring, emergency readiness, and an increase in the complexity of veterinary therapeutics. Therefore, significant trends that can be noticed during the said period would be the contracting out of research and development, the infusion of technology, alliances and partnerships, sustainable manufacturing practices, and the move towards digital veterinary services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What Drivers Are Propelling the Growth of Veterinary CRO And CDMO Market Forward?
The veterinary CRO and CDMO market is predicted to expand due to a surge in animal healthcare investments. Recent years have seen an upward trend in such investments, spurred by heightened understanding of animal health and an increased need for veterinary products and services. This, in turn, contributes positively to the veterinary CRO and CDMO market's growth. For example, the American Pet Products Association (APPA), a non-profit organization that advocates for pet ownership and the pet product industry, reported in October 2023 that annual pet care spending in the U.S. jumped from USD 123.6 billion in 2021 to 136.8 billion in 2022. Consequently, as investments in animal healthcare continue to rise, so too will the growth of the veterinary CRO and CDMO market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Which Emerging Trends Are Transforming the Veterinary CRO And CDMO Market in 2025?
In the veterinary CRO and CDMO market, the primary trend gaining traction is product innovation. To maintain their market foothold, businesses in the veterinary CRO and CDMO arena are prioritizing product innovation. For example, Vetio, an American CDMO committed to animal health, received an intention to grant from the European Patent Office (EPO) and a notice of allowance from the United States Patent Office (USPTO) for its Starch-Free Soft Chew meant for veterinary use in June 2022. Developed specifically for animal health, Vetio's Soft Chew Technology platform adeptly delivers one or more active ingredients in a high-quality dosage form apt for veterinary pharmaceutical use. Vetio's unique composition and manufacturing technique exclude starch and added water, making it significantly appropriate for moisture-sensitive active ingredients.

What Are the Key Segments in the Veterinary CRO And CDMO Market?
The veterinary cro and cdmo market covered in this report is segmented -

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:
1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization
2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting
3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services
4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance
5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Who Are the Key Players Shaping the Veterinary CRO And CDMO Market's Competitive Landscape?
Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.

What Geographic Markets Are Powering Growth in the Veterinary CRO And CDMO Market?
North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.